title: Advanced malignant insulinoma. Everolimus response and toxicity.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, Madrid, España. Electronic address: cuestamartintutor@gmail.com.
authors.forename: Martín
authors.initials: M
authors.lastname: Cuesta Hernández
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, Madrid, España.
authors.forename: Emilia
authors.initials: E
authors.lastname: Gómez Hoyos
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, Madrid, España.
authors.forename: Clara
authors.initials: C
authors.lastname: Marcuello Foncillas
authors.affiliation: Servicio de Oncología Médica, Hospital Clínico San Carlos, Madrid, España.
authors.forename: Javier
authors.initials: J
authors.lastname: Sastre Valera
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, Madrid, España.
authors.forename: José Ángel
authors.initials: JÁ
authors.lastname: Díaz Pérez
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D057176:Compassionate Use Trials; D019008:Drug Resistance, Neoplasm; D057915:Drug Substitution; D000068338:Everolimus / Q000009:adverse effects / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007003:Hypoglycemia / Q000209:etiology; D007340:Insulinoma / Q000188:drug therapy* / Q000556:secondary; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced*
chemical_list: D000068338:Everolimus